CSL Behring’s Warfarin Antidote Kcentra Gets Green Light From FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Kcentra is approved as an effective alternative to frozen plasma when patients on chronic warfarin to avoid clots suddenly find themselves in a bleeding emergency where they need their blood to clot fast, though Kcentra is not without risks of its own.